Page last updated: 2024-11-04

vorinostat and Cardiomyopathies

vorinostat has been researched along with Cardiomyopathies in 1 studies

Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).

Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Colussi, C1
Rosati, J1
Straino, S1
Spallotta, F1
Berni, R1
Stilli, D1
Rossi, S1
Musso, E1
Macchi, E1
Mai, A1
Sbardella, G1
Castellano, S1
Chimenti, C1
Frustaci, A1
Nebbioso, A1
Altucci, L1
Capogrossi, MC1
Gaetano, C1

Other Studies

1 other study available for vorinostat and Cardiomyopathies

ArticleYear
Nε-lysine acetylation determines dissociation from GAP junctions and lateralization of connexin 43 in normal and dystrophic heart.
    Proceedings of the National Academy of Sciences of the United States of America, 2011, Feb-15, Volume: 108, Issue:7

    Topics: Acetylation; Anacardic Acids; Animals; Cardiomyopathies; Connexin 43; Gap Junctions; Histone Acetylt

2011